Many neurological diseases damage specific parts of the brain, even though the harmful protein involved is present throughout the brain.

Scientists discovered that a key brain signal may have been pointing researchers in the wrong direction, potentially changing ...

Corey Hopkins, director of the UNMC Center for Drug Design and Innovation, points to the 11h chemical formula tattooed on his arm. About four years ago, he started getting patented chemicals created ...

Levacetylleucine (Aqneursa) improved neurologic symptoms and functioning in adults and children with ataxia-telangiectasia in ...

Omaveloxolone (Omav) is the first and only licensed treatment for adults with Friedreich’s Ataxia (FA). Hosted by Jonathan Brash MP and Mary Glindon MP at Portcullis House, the Parliamentary Drop-In ...

Joubert syndrome (JS) is a rare ciliopathy characterised by the molar tooth sign on brain MRI, cerebellar vermis hypoplasia, hypotonia and developmental delay. We report an elementary school-aged boy ...

Scientists may have discovered a new role for the cerebellum, the part of the brain that sits at the base of the skull. A new paper published in the journal Nature Neuroscience reports that different ...

The cerebellum, the wizened “little brain” nestled in the base of the skull, may help keep us sharp as we age. Regions at the back of the cerebellum that resisted shrinkage with age were tied to ...

Only successful pivotal Phase III trial in Ataxia-Telangiectasia (A-T), a rare, progressive neurodegenerative disease with no approved treatments Phase III trial successfully achieved its primary ...